FBP FIRST BANCORP
Permanent stock page ↗Financials · Russell 2000
Next earnings: Wed 27 Jan 2027 · estimated
What 9 analyst firms say about FIRST BANCORP: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
8 rated views · 9 analyst/firm records · 9 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8063
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8060
Recent analyst activity · last 90 days
Our tracked history has 9 reports on FBP from 6 analyst firms in the last 90 days (9 firms in the past year).
Comparing each firm's latest target with its previous one: 1 raised its price target, 1 lowered it and 2 left it unchanged.
No firm's latest available rating differs from its previous one.
Latest observed target change: Truist raised its target from $26.00 (set 23 Apr 2026) to $31.00 on 27 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Benchmark | Brett Rabatin | Buy | 26 Oct 2026 | 32.00 USD |
| Hovde Group | Unnamed analyst | Buy | 28 Jan 2026 | 26.00 USD |
| Keefe Bruyette & Woods | Kelly Motta | Hold | 23 Jul 2026 | 31.00 USD |
| Piper Sandler | Manuel Navas | Hold | 23 Jul 2026 | 25.00 USD · 23 Apr 2026 |
| Raymond James | Steve Moss | Buy | 27 Oct 2026 | 32.00 USD · 6 Oct 2026 |
| Truist | Arren Cyganovich | Buy | 27 Oct 2026 | 31.00 USD |
| Weiss Ratings | Unnamed analyst | — | 27 Aug 2026 | — |
| Wells Fargo | Terry McEvoy | Buy | 29 Sep 2026 | 32.00 USD |
| Data feed RESEARCH | Research Team | Hold | 23 Sep 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 04:43 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.